NGM Bio To Present Phase 2 Data Of NGM282 In NASH At International Liver...
SOUTH SAN FRANCISCO Calif. April 5 2017 PRNewswire NGM Bio a researchdriven biotechnology company that translates powerful biology into transformative medicines today announced that new data from the...
View ArticleStatinAssociated Myalgia and Vitamin D Deficiency in HIV
A new study explores the connection between vitamin D deficiency and the risk for statinrelated myalgia among HIV patients receiving antiretroviral therapy. AIDS
View ArticleMorning Report StatinDiabetes Link in Older Women
Dr Arefa Cassoobhoy highlights one of the week's most important news stories for primary care. Medscape Internal Medicine
View ArticleCardioBreak HVAD Mixed Results; New Echo Classifications; Tx for Statin...
MedPage Today Recent developments of interest in cardiovascular medicine
View ArticleMinneapolis study finds most major heart attacks occur in people with normal...
Allina Health Researchers wanted to find out if new statin guidelines were affecting the number of heart attacks. What they found was promising but revealed a basic flaw in preventive care.
View ArticleMost major heart attacks occur in people with normal cholesterol research finds
Researchers wanted to find out if new statin guidelines were affecting the number of heart attacks. What they found was promising but revealed a basic flaw in preventive care.
View ArticlePharmaPoint Dyslipidemia Global Drug Forecast and Market Analysis to 2025...
PharmaPoint Dyslipidemia Global Drug Forecast and Market Analysis to 2025SummaryGlobalData estimates sales of dyslipidemia therapeutics to be approximately $11.2B across the 7MM in 2015 encompassing...
View ArticleComparison of Statin Eligibility by USPSTF and ACCAHA Criteria
This study uses NHANES data to compare the numbers of US adults eligible for primary prevention statin treatment under USPSTF vs ACCAHA guideline criteria.
View ArticleAdherence to USPSTF recommendations could lead to lower number of individuals...
Fewer people could be recommended for primary prevention statin therapy including many younger adults with high longterm cardiovascular disease risk if physicians adhere to the 2016 U.S. Preventive...
View ArticleConflicting Statin Guidelines Leave Millions in 'Gray Zone'
TUESDAY April 18 2017 Conflicting guidelines on statin use could leave about 9 million Americans unsure about treatment a new study suggests.Researchers estimate that if all doctors followed the latest...
View ArticleAdherence to highintensity statin dropsoff for many following heart attack
A substantial proportion of patients prescribed highintensity statins following hospitalization for a heart attack did not continue taking this medication with high adherence at two years after...
View ArticleKowa Pharmaceuticals America Inc. Announces INTREPID Trial Results in The...
INTREPID is first prospective randomized doubleblind activecontrolled headtohead statin trial evaluating the efficacy and safety of statin therapy in adults with HIV and dyslipidemia taking...
View ArticleDo Latest US Guidelines Bypass or Spare Millions From Statins
Some 9 million fewer Americans would be recommended for primaryprevention statin therapy under the USPSTF guidelines but experts agree the optimal statin guideline doesn't exist. Heartwire from Medscape
View ArticleMany Heart Attack Patients Fail to Stick With Statins
WEDNESDAY April 19 2017 High doses of powerful statin drugs have been shown to avert future heart problems including heart attack and stroke. Yet many heart attack patients stop taking these medicines...
View ArticleMost Medicare beneficiaries do not adhere to highintensity statin...
After two years of hospital discharge 41.6 percent of Medicare beneficiaries who were hospitalized for MI were taking hi
View ArticleCan Cholesterol Drug Sponsors Make The Case For Statin Intolerance
Amgen&39;s FOURIER outcomes study of Repatha supports LDLlowering in high risk patients but price may have to come down dramatically...&160;&160;&160;
View ArticleWhite Flag Raised UniQure Gives Up On Glybera But Not Gene Therapies
UniQure will not seek marketing authorization renewal for Glybera in the EU before it expires in October but the company...&160;&160;&160;&160;
View ArticleApr 21 Cardiology News
Highsensitivity troponin statin eligibility FDA letter to Abbott azithromycin risks transfat ban and trust in medical science are discussed by Dr John Mandrola in this week's podcast. theheart.org on...
View ArticleWesternUs Ray Symposium Tackles Drug Pricing
Dana Goldman PhD Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy Public Policy and Economics at the University of Southern California served as the keynote speaker for Western...
View Article1Q Pharma Results Preview Biogen Novartis Lilly Amgen AstraZeneca BMS AbbVie...
Scrip offers some key points to watch for as the biopharmaceutical sales and earnings start to roll in. While the...&160;&160;&160;
View Article